Brussels, 08/05/2007 (Agence Europe) - On Friday 4 May, the government of President Luiz Ignacio Lula da Silva decided to break off negotiations on intellectual property rights called for by the company Merck Sharp and Dohme, and to permit the production and sales of a generic version of the drug Efavirenz, which is used in the treatment of 75,000 Brazilian patients infected by HIV, the Parliamentary group European United Left/Nordic Green Left (GUE/NGL) has announced. The group welcomes...